[1]梁燕,包晓航,段光友,等.妊娠合并心脏病患者剖宫产的麻醉管理回顾性分析[J].第三军医大学学报,2018,40(20):1889-1893.
 LIANG Yan,BAO Xiaohang,DUAN Guangyou,et al.Anesthetic management in cesarean section in women with heart disease: analysis of 96 cases[J].J Third Mil Med Univ,2018,40(20):1889-1893.
点击复制

妊娠合并心脏病患者剖宫产的麻醉管理回顾性分析(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
40卷
期数:
2018年第20期
页码:
1889-1893
栏目:
临床医学
出版日期:
2018-10-30

文章信息/Info

Title:
Anesthetic management in cesarean section in women with heart disease: analysis of 96 cases
作者:
梁燕包晓航段光友李洪
陆军军医大学(第三军医大学)第二附属医院麻醉科
Author(s):
LIANG Yan BAO Xiaohang DUAN Guangyou LI Hong

Department of Anesthesia, Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400037, China

关键词:
麻醉管理妊娠心脏病剖宫产预后
Keywords:
anesthetic management pregnancy heart diseases cesarean section neonatal outcomes
分类号:
R614;R714.252;R719.8
文献标志码:
A
摘要:

目的    总结妊娠合并心脏病孕产妇剖宫产的麻醉管理经验,分析不同麻醉方式和心脏病类型对孕产妇和新生儿预后的影响。方法    筛选我院在2015年1月至2017年12月期间诊断为妊娠合并心脏病并择期行剖宫产术的孕产妇96例,年龄(27.4±4.9)岁,孕(37.30±2.45)周,BMI:26.20±3.31。依据麻醉方式分为:硬膜外麻醉组(n=63)、蛛网膜下腔阻滞组(n=21)和全身麻醉组(n=12);依据心脏病类型分为:先天性心脏病组(n=33)、先天性心脏病术后组(n=31)、瓣膜置换术后组(n=21)、围产期心肌病组(n=4)和肺动脉高压组(n=7)。统计分析不同麻醉方式对合并心脏病孕产妇和新生儿预后的影响,以及不同心脏病类型孕产妇及其新生儿的预后。结果①蛛网膜下腔阻滞后血管活性药物使用率最高,全身麻醉最低(P<0.05);②硬膜外麻醉的麻醉至手术开台时间较其他两组长(P<0.05),不同麻醉方式术中输液量、新生儿Apgar评分和产妇术后ICU停留时间均无统计学差异(P>0.05);③以心脏病类型分组中:术中输液量和出血量无统计学差异(P>0.05),围产期心肌病组和肺动脉高压组新生儿Apgar评分较其他组低(P<0.05),产妇术后ICU停留时间较其他组长(P<0.05)。结论     ①蛛网膜下腔阻滞后低血压发生率高,但经血管活性药物治疗后,不影响产妇及新生儿的预后;②全身麻醉虽有潜在气管插管困难和反流误吸的风险,但其循环稳定、麻醉至手术开台时间短,并不增加孕产妇心脏病并发症的发生率和降低新生儿Apgar评分;③合并围产期心肌病和肺动脉高压孕产妇围术期易发生心衰和肺动脉高压危象。

Abstract:

Objective   To review our experience with anesthetic management in cesarean section in women with different heart diseases and analyze how different anesthesia management and heart diseases affect pregnancy and neonatal outcomes. Methods    We retrospectively collected the data from 96 pregnant women with heart disease (mean age 27.4±4.9 years, at 37.30±2.45 weeks’ gestation with a mean body mass index of 26.20±3.31) undergoing elective cesarean section in our hospital between January, 2015 and December, 2017. Cesarean section was performed under epidural anesthesia (n=63), spinal anesthesia (n=21), or general anesthesia (n=12). The women were found to have congenital heart disease (n=33), a history of surgery for congenital heart disease (n=31), a history of valve replacement (n=21), perioperative cardiomyopathy (n=4), or pulmonary hypertension (n=7). The pregnancy and neonatal outcomes were compared across different anesthesia management and different heart diseases. Results    ①The rate of use of vasoactive drugs was the highest with spinal anesthesia and the lowest with general anesthesia (P<0.05). ②The onset time of anesthesia was significantly longer with epidural anesthesia than with spinal anesthesia and general anesthesia (P<0.05). The volume of intraoperative fluid infusion, neonatal Apgar scores and the length of postoperative ICU stay did not differ significantly among the women receiving different anesthesia management (P>0.05). ③The volume of intraoperative fluid infusion and bleeding were similar among the women with different heart diseases (P>0.05), but in women with perioperative cardiomyopathy and pulmonary hypertension, the neonatal Apgar scores were significantly lower (P<0.05) and postoperative ICU stay was significantly longer (P<0.05) than those in women with other types of heart diseases. Conclusion    ①Hypotension is a common complication after spinal anesthesia for cesarean section but does not significantly affect the pregnancy or neonatal outcomes. ②General anesthesia, though with the risks of difficult airway and aspiration of gastric contents, can achieve stable circulation and more rapid onset of anesthesia and does not increase the complications of pregnancy or reduce neonatal Apgar scores. ③Pregnant women with perioperative cardiomyopathy and pulmonary hypertension are at high risks of perioperative heart failure and pulmonary hypertension crisis.

参考文献/References:

[1]ISOGAI T, MATSUI H, TANAKA H, et al. Clinical features and peripartum outcomes in pregnant women with cardiac disease: a nationwide retrospective cohort study in Japan[J]. Heart Vessels, 2018, 33(8): 918-930. DOI: 10.1007/s0038001811371.
[2]罗来敏, 戴钟英.上海市15年妊娠合并心脏病的临床资料分析[J]. 中华妇产科杂志, 1997, 32(6): 336-340. DOI: 10.3760/j.issn: 0529567X.1997.06.005.
LUO L M, DAI Z Y.Retrospective epidemiological study of pregnancy complicated by heart disease during 15 years in Shanghai[J].Chin J Obstet Gynecol, 1997, 32(6): 336340. DOI: 10.3760/j.issn: 0529567X.1997.06.005.
[3]牟大英, 王豫黔.妊娠合并心脏病60例临床分析[J]. 遵义医学院学报, 2010, 33(5): 468-472. DOI: 10.3969/j.issn.10002715.2010.05.021.
MU D Y, WANG Y Q.Clinical analysis of 60 cases pregnancy complicated by heart disease[J]. J Zunyi Med Univ, 2010, 33(5): 468-472. DOI: 10.3969/j.issn.10002715.2010.05.021.
[4]KAMPMAN M A, VALENTE M A, VAN MELLE J P, et al. Cardiac adaption during pregnancy in women with congenital heart disease and healthy women[J]. Heart, 2016, 102(16): 1302-1308. DOI: 10.1136/heartjnl2015308946.
[5]RAY P, MURPHY G J, SHUTT L E. Recognition and management of maternal cardiac disease in pregnancy[J]. Br J Anaesth, 2004, 93(3): 428-439. DOI: 10.1093/bja/aeh194.
[6]GRASSMANN C, HENRY O. Peripartum outcomes and the anaesthetic management of parturients with mild to moderate congenital heart disease[J]. Anaesthesia, 2017, 72(Supplement 4): 54-57. DOI: 10.1111/anae.14060.
[7]HAMLYN E L, DOUGLASS C A, PLAAT F, et al. Lowdose sequential combined spinalepidural: an anaesthetic technique for caesarean section in patients with significant cardiac disease[J]. Int J Obstet Anesth, 2005, 14(4): 355-361. DOI: 10.1016/j.ijoa.2005.01.001.
[8]LUCAS D N, BAMBER J H. UK Confidential enquiry into maternal deaths—still learning to save mothers’ lives[J]. Anaesthesia, 2018, 73(4): 416-420. DOI: 10.1111/anae.14246.
[9]ABE H, SUMITANI M, UCHIDA K, et al. Association between mode of anaesthesia and severe maternal morbidity during admission for scheduled Caesarean delivery: a nationwide populationbased study in Japan, 20102013[J].Br J Anaesth, 2018, 120(4): 779-789. DOI: 10.1016/j.bja.2017.11.101.
[10]KARAMAN S, AKERCAN F, ALDEMIR O, et al. The maternal and neonatal effects of the volatile anaesthetic agents desflurane and sevoflurane in caesarean section: a prospective,  randomized clinical study[J]. J Int Med Res, 2006, 34(2): 183-192. DOI: 10.1177/147323000603400208.
[11]GREUTMANN M, SILVERSIDES C K. The ROPAC registry: a multicentre collaboration on pregnancy outcomes in women with heart disease[J]. Eur Heart J, 2013, 34: 634-635. DOI: 10.1093/eurheartj/ehs335.
[12]ERTEKIN E, VAN HAGEN I M, SALAM A M, et al. Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology[J].Int J Cardiol, 2016, 220: 131-136. DOI: 10.1016/j.ijcard.2016.06.061.
[13]SIU S C, SERMER M, COLMAN J M, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease[J]. Circulation, 2001, 104(5): 515-521. DOI: 10.1016/S10621458(01)005992.
[14]DAVIES G A, HERBERT W N. Cardiac disease in pregnancy[J].Anaesthesia & Intensive Care Med, 2016, 17(8): 390-394. DOI: 10.1016/j.mpaic.2016.05.010.
[15]KHAIRY P, IONESCUITTU R, MACKIE A S, et al. Changing mortality in congenital heart disease[J]. J Am Coll Cardiol, 2010, 56(14): 1149-1157. DOI: 10.1016/j.jacc.2010.03.085.
[16]周晓瑞, 张京岚, 卢家凯, 等. 妊娠合并肺动脉高压149例临床分析[J]. 心肺血管病杂志, 2013, 32(5): 544-548.DOI: 10.3969/j.issn.10075062.2013.05.003.
ZHOU X R,  ZHANG J L, LU J K, et al. Clinical analysis of 149 cases of pregnant women with pulmonary arterial hypertension[J]. J Cardiovasc Pulmonary Dis, 2013, 32(5): 544-548. DOI: 10.3969/j.issn.10075062.2013.05.003.
[17]REGITZZAGROSEK V, LUNDQVIST C B, BORGHI C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2011, 32(24): 3147-3197.DOI: 10.1093/eurheartj/ehr218.
[18]BHATTACHARYA S,  GHOSH S,  RAY D, et al. Oxytocin administration during cesarean delivery: Randomized controlled trial to compare intravenous bolus with intravenous infusion regimen[J].J Anaesthesiol Clin Pharmacol, 2013, 29(1): 32-35. DOI: 10.4103/09709185.105790.
[19]DYER R A, BUTWICK A J, CARVALHO B.Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist[J].Curr Opin Anaesthesiol, 2011, 24(3): 255-261. DOI: 10.1097/ACO.0b013e328345331c.
[20]RAMZY J, NEW G, CHEONG A, et al. Iatrogenic anterior myocardial infarction secondary to ergometrineinduced coronary artery spasm during dilation and curettage for an incomplete miscarriage[J].Int J Cardiol, 2015, 198: 154-156. DOI: 10.1016/j.ijcard.2015.06.106.

相似文献/References:

[1]冯丽霞,李力,俞丽丽,等.妊娠肝内胆汁淤积症胎兔心肌细胞损伤的研究[J].第三军医大学学报,2009,31(04):334.
 FENG Li-xia,LI Li,YU Li-li,et al.Cardiac myocyte damage in fetus of rabbits with intrahepatic cholestasis pregnant[J].J Third Mil Med Univ,2009,31(20):334.
[2]俞丽丽,李力,易萍,等.妊娠合并重度血小板减少症的临床研究[J].第三军医大学学报,2008,30(04):350.
[3]陈丹,吴庆琛.心脏机械瓣膜置换术后妊娠与分娩229例临床分析[J].第三军医大学学报,2007,29(14):1451.
[4]王琳,常青,陈城.妊娠合并急性肝功能衰竭1例[J].第三军医大学学报,2007,29(13):1392.
[5]唐固平,李波.50例妊娠期妇女凝血指标变化及其意义[J].第三军医大学学报,2008,30(23):2202.
[6]张晓菲,王凤英,李玉艳,等.妊娠期梅毒血清学阳性患者的处理与妊娠结局[J].第三军医大学学报,2005,27(24):2469.
[7]王静波,常青,陈勇,等.妊娠肝内胆汁淤积症孕妇血清和脐血清一氧化氮变化及胎盘一氧化氮合酶的表达[J].第三军医大学学报,2005,27(18):1907.
[8]王琳,王延洲.孕36周合并晚期胆囊癌1例[J].第三军医大学学报,2009,31(12):1192.
[9]曾毅,王琳.妊娠期巨乳合并急性淋巴细胞白血病1例[J].第三军医大学学报,2010,32(02):154.
[10]曾毅,王琳.妊娠合并肝血管瘤破裂出血1例[J].第三军医大学学报,2010,32(03):213.

更新日期/Last Update: 2018-11-01